Amyloidosis Support Groups Inc
Balance Sheet
Fiscal Year Start:
Jun 1
Assets in 2025 (Year End)
$1,165,178
Cash & Equivalents
>99%
Investments
<1%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2025 (Year End)
$10,911
Notes Payable / Debt (Non-Related)
>99%
Payables & Accruals
0%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2024
2025
Change
Cash & Equivalents
$849,654
$1,155,203
+36%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
$35,141
$9,975
-72%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$884,795
$1,165,178
+32%
Liabilities
2024
2025
Change
Payables & Accruals
-
-
-
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$6,367
$10,911
+71%
Related-Party Payables
-
-
-
Other Liabilities
$0
$0
-
Total Liabilities
$6,367
$10,911
+71%
Net assets
2024
2025
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$878,428
$1,154,267
+31%
Net assets
2024
2025
Change
Net assets
+$878,428
+$1,154,267
+31%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)